Published in Toxicon on September 01, 2001
Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A (2004) 1.29
Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nat Clin Pract Urol (2008) 1.00
Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol (2014) 0.88
Onset dynamics of type A botulinum neurotoxin-induced paralysis. J Pharmacokinet Pharmacodyn (2008) 0.87
Temporal characteristics of botulinum neurotoxin therapy. Expert Rev Neurother (2010) 0.80
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest (1998) 4.92
Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol (1999) 1.41
The putative agrin receptor binds ligand in a calcium-dependent manner and aggregates during agrin-induced acetylcholine receptor clustering. Neuron (1991) 1.07
Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr (2001) 1.06
Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci (1997) 1.06
Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev Dyn (1997) 1.02
Localization of sialidase in the plasma membrane of rat liver cells. J Biol Chem (1972) 1.00
The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol (1999) 0.99
Intracellular location and properties of bovine brain sialidase. J Biol Chem (1970) 0.91
Sialidase activity in transformed cells. J Biol Chem (1973) 0.90
Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers. Biochem Pharmacol (1998) 0.83
Ecto-ganglioside-sialidase activity of herpes simplex virus-transformed hamster embryo fibroblasts. J Cell Biol (1976) 0.83
Solubilization and partial characterization of a tumor-rejection antigen from an ultraviolet light-induced murine tumor. Int J Cancer (1981) 0.83
Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study. Cancer (1985) 0.82
Oxidation and base-catalyzed elimination of the saccharide portion of GSLs having very different polarities. J Lipid Res (2001) 0.81
Sex steroids promote neurite growth in mesencephalic tyrosine hydroxylase immunoreactive neurons in vitro. Int J Dev Neurosci (1987) 0.80
Oligosaccharide-derivatized dendrimers: defined multivalent inhibitors of the adherence of the cholera toxin B subunit and the heat labile enterotoxin of E. coli to GM1. Glycoconj J (1997) 0.80
VCN-releasable sialic acid and gangliosides in human neuroblastomas. J Pediatr Surg (1977) 0.80
Sialidase activity of oncogenic cells transformed by herpes simplex virus. Virology (1974) 0.78
Neuronal and non-neuronal properties of neuroblastoma cells. Exp Cell Res (1978) 0.77
Distribution in spleen subcellular organelles of sialidase active towards natural sialogylcolipid and sialoglycoprotein substrates. Biochim Biophys Acta (1979) 0.77
A biochemical analysis of thoracic neuroblastomas: a Pediatric Oncology Group study. J Pediatr Surg (1987) 0.77
Differential accumulation of gangliosides by the brains of MPTP-lesioned mice. J Neurosci Res (1994) 0.76
Oxidative degradation of glycosphingolipids revisited: a simple preparation of oligosaccharides from glycosphingolipids. Carbohydr Res (1986) 0.76
Effects of coculture on the morphology of identified raphe and substantia nigra neurons from the embryonic rat brain. J Neurosci Res (1987) 0.76
Murine neuroblastoma cells express ganglioside binding sites on their cell surface. J Neurochem (1990) 0.75
Effects of specific gangliosides on the in vitro proliferation of MPTP-susceptible cells. J Neurochem (1993) 0.75
Partial characterization of a brain extract factor(s) inhibitory to transformed neural cells. J Neurosci Res (1985) 0.75
Nonmuscle myosin heavy chain B is recognized by a monoclonal antibody that inhibits GM1-enhanced neuritogenesis. J Neurochem (1997) 0.75
Identification of a GM1-binding protein on the surface of murine neuroblastoma cells. J Neurochem (1992) 0.75
A comparative study of gangliosides from brains of various species. Lipids (1969) 0.75
Gangliosides, glycosidases, and sialidase in the brain and eyes of developing chickens. Biochemistry (1971) 0.75
Biochemical and morphological study of adriamycin-induced changes in murine neuroblastoma cells. Oncology (1982) 0.75
Influence of cation concentration on the sialidase activity of neuronal synaptic membranes. Biochem Biophys Res Commun (1975) 0.75
Response of mature mice to challenge with neuroblastoma after inoculation with neuroblastoma cells as neonates. Cancer Lett (1983) 0.75
Development of a neonatal and metastatic murine neuroblastoma model. Cancer Res (1979) 0.75
Differential enrichment of cells from embryonic rat cerebra by centrifugal elutriation. J Neurochem (1979) 0.75
Microfluorimetry of brain glycolipid. Theoretical and applied analysis of PAS fluorescence and dye concentration. J Histochem Cytochem (1978) 0.75
Density-dependent changes in gangliosides and sialidase activity of murine neuroblastoma cells. J Neurochem (1982) 0.75
Effects of exogenous GM1 and GD1a on S20Y neuroblastoma cells. J Neurosci Res (1984) 0.75
Cellular effects of a brain extract factor or factors inhibiting neuroblastoma cell growth in vitro. J Neurosci Res (1986) 0.75
Neuron-specific enolase levels in primary cultures of neurons. J Neurosci Res (1980) 0.75
Association of endogenous substrate with solubilized bovine brain sialidase. J Neurosci Res (1986) 0.75
Cell culture of sixteen-day-old rat embryo cerebra and associated changes in ganglioside pattern. J Neurochem (1977) 0.75